Excipient Traceability

Pharmaceutical Excipient Distribution Supply Chain Traceability Rules

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Introducing IPEC-PQG GMP/GDP rules for pharmaceutical excipients during distribution, split packaging, relabeling, and label reprint controls.

Key answer

Because excipients often travel through multiple distributors, risks of lost batch codes, mix-ups, or adulteration (e.g., diethylene glycol in glycerin) are high. Under IPEC GDP guidelines, distributors must maintain a bidirectional traceability chain from original manufacturer to the pharma client. If repackaging or relabeling occurs, it must comply with GMP cleanroom packing rules, and editing original batch codes is barred.

Critical Audit Checkpoints in Excipient Repackaging Sites

When auditing repackaging facilities, quality managers must inspect the following physical and documentation control bottlenecks.

  • Environment: air filtration systems (Grade D/ISO 8) and pressure checks in packing rooms
  • Equipment cleaning: material compliance declarations and cleaning logs for shared hoppers, scoops, and sealers
  • Label controls: reprinted labels showing original and repackaged batch codes, with clearance checklists

FAQ

Which excipients carry high diethylene glycol (DEG) adulteration risks?+

Liquid polyols like Glycerin, Propylene Glycol, and Sorbitol carry high DEG contamination history. The FDA mandates gas chromatography testing for DEG/EG on every incoming lot; relying on supplier COAs for release is not allowed.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.